Gemtuzumab ozogamicin (Mylotarg)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Gemtuzumab ozogamicin (Mylotarg), covering 2009-08-21 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome [Phase 2]